Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 2001 Nov;85(10):1572–1576. doi: 10.1054/bjoc.2001.2124

Protoporphyrin IX distribution following local application of 5-aminolevulinic acid and its esterified derivatives in the tissue layers of the normal rat colon

E Endlicher 1, P Rümmele 2, F Hausmann 3, R Krieg 1, R Knüchel 2, H C Rath 1, J Schölmerich 1, H Messmann 1
PMCID: PMC2363929  PMID: 11720447

Abstract

Photodynamic diagnosis and especially therapy after sensitization with 5-aminolevulinic acid (ALA) is hampered by limitations of uptake and distribution of ALA due to its hydrophilic nature. Chemical modification of ALA into its more lipophilic esters seems to be promising to overcome these problems. The aim of the present study was to investigate the comparative kinetics of protoporphyrin IX (PPIX) fluorescence in rat colonic tissue after topical application of ALA and its esterified derivatives, ALA-hexylester (h-ALA), ALA-methylester (m-ALA) and ALA-benzylester (b-ALA). Fluorescence intensity induced by PPIX in normal colonic tissue was quantified using fluorescence microscopy at 1, 2, 4, 6 and 8 h after sensitization. Mucosa exhibited higher fluorescence levels compared to the underlying submucosa or smooth muscle. Peak fluorescence intensities were seen 4 h after local sensitization with 86.0 mol ml−1 ALA (513 ± 0.57 counts per pixel), 6.6 mol ml−1 m-ALA (508 ± 35.50) and 4.8 mol ml−1 h-ALA (532 ± 128.80), and 6 h after sensitization with 4.6 mol ml−1 b-ALA (468 ± 190.27). A 13–18 times lower concentration of ALA esters was required for fluorescence intensities reached with ALA alone. A similar degree of the fluorescence ratio between mucosa and muscularis (5–6:1) was detected for ALA and its derivatives. The time point of the maximum value of this ratio was consistent with peak fluorescence levels for ALA and each ALA-ester. The clinical feasibility and the advantages of topical ALA ester-based fluorescence for detection of malignant and premalignant lesions need further investigations. © 2001 Cancer Research Campaign   http://www.bjcancer.com

Keywords: 5-aminolevulinic acid, 5-aminolevulinic esters, protoporphyrin IX, fluorescence, colon

Full Text

The Full Text of this article is available as a PDF (91.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bedwell J., MacRobert A. J., Phillips D., Bown S. G. Fluorescence distribution and photodynamic effect of ALA-induced PP IX in the DMH rat colonic tumour model. Br J Cancer. 1992 Jun;65(6):818–824. doi: 10.1038/bjc.1992.175. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Casas A., Batlle A. M., Butler A. R., Robertson D., Brown E. H., MacRobert A., Riley P. A. Comparative effect of ALA derivatives on protoporphyrin IX production in human and rat skin organ cultures. Br J Cancer. 1999 Jul;80(10):1525–1532. doi: 10.1038/sj.bjc.6690556. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Eléouet S., Rousset N., Carré J., Bourré L., Vonarx V., Lajat Y., Beijersbergen van Henegouwen G. M., Patrice T. In vitro fluorescence, toxicity and phototoxicity induced by delta-aminolevulinic acid (ALA) or ALA-esters. Photochem Photobiol. 2000 Apr;71(4):447–454. doi: 10.1562/0031-8655(2000)071<0447:ivftap>2.0.co;2. [DOI] [PubMed] [Google Scholar]
  4. Endlicher E., Knuechel R., Hauser T., Szeimies R. M., Schölmerich J., Messmann H. Endoscopic fluorescence detection of low and high grade dysplasia in Barrett's oesophagus using systemic or local 5-aminolaevulinic acid sensitisation. Gut. 2001 Mar;48(3):314–319. doi: 10.1136/gut.48.3.314. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Filbeck T., Roessler W., Knuechel R., Straub M., Kiel H. J., Wieland W. F. Clinical results of the transurethreal resection and evaluation of superficial bladder carcinomas by means of fluorescence diagnosis after intravesical instillation of 5-aminolevulinic acid. J Endourol. 1999 Mar;13(2):117–121. doi: 10.1089/end.1999.13.117. [DOI] [PubMed] [Google Scholar]
  6. Gaullier J. M., Berg K., Peng Q., Anholt H., Selbo P. K., Ma L. W., Moan J. Use of 5-aminolevulinic acid esters to improve photodynamic therapy on cells in culture. Cancer Res. 1997 Apr 15;57(8):1481–1486. [PubMed] [Google Scholar]
  7. Gossner L., Stolte M., Sroka R., Rick K., May A., Hahn E. G., Ell C. Photodynamic ablation of high-grade dysplasia and early cancer in Barrett's esophagus by means of 5-aminolevulinic acid. Gastroenterology. 1998 Mar;114(3):448–455. doi: 10.1016/s0016-5085(98)70527-x. [DOI] [PubMed] [Google Scholar]
  8. Kloek J., Akkermans W., Beijersbergen van Henegouwen G. M. Derivatives of 5-aminolevulinic acid for photodynamic therapy: enzymatic conversion into protoporphyrin. Photochem Photobiol. 1998 Jan;67(1):150–154. [PubMed] [Google Scholar]
  9. Koenig F., McGovern F. J., Larne R., Enquist H., Schomacker K. T., Deutsch T. F. Diagnosis of bladder carcinoma using protoporphyrin IX fluorescence induced by 5-aminolaevulinic acid. BJU Int. 1999 Jan;83(1):129–135. doi: 10.1046/j.1464-410x.1999.00917.x. [DOI] [PubMed] [Google Scholar]
  10. Krieg R. C., Fickweiler S., Wolfbeis O. S., Knuechel R. Cell-type specific protoporphyrin IX metabolism in human bladder cancer in vitro. Photochem Photobiol. 2000 Aug;72(2):226–233. doi: 10.1562/0031-8655(2000)072<0226:ctspim>2.0.co;2. [DOI] [PubMed] [Google Scholar]
  11. Kriegmair M., Baumgartner R., Knüchel R., Stepp H., Hofstädter F., Hofstetter A. Detection of early bladder cancer by 5-aminolevulinic acid induced porphyrin fluorescence. J Urol. 1996 Jan;155(1):105–110. [PubMed] [Google Scholar]
  12. Lange N., Jichlinski P., Zellweger M., Forrer M., Marti A., Guillou L., Kucera P., Wagnières G., van den Bergh H. Photodetection of early human bladder cancer based on the fluorescence of 5-aminolaevulinic acid hexylester-induced protoporphyrin IX: a pilot study. Br J Cancer. 1999 Apr;80(1-2):185–193. doi: 10.1038/sj.bjc.6690338. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Loh C. S., MacRobert A. J., Bedwell J., Regula J., Krasner N., Bown S. G. Oral versus intravenous administration of 5-aminolaevulinic acid for photodynamic therapy. Br J Cancer. 1993 Jul;68(1):41–51. doi: 10.1038/bjc.1993.284. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Overholt B. F., Panjehpour M., Haydek J. M. Photodynamic therapy for Barrett's esophagus: follow-up in 100 patients. Gastrointest Endosc. 1999 Jan;49(1):1–7. doi: 10.1016/s0016-5107(99)70437-2. [DOI] [PubMed] [Google Scholar]
  15. Peng Q., Warloe T., Berg K., Moan J., Kongshaug M., Giercksky K. E., Nesland J. M. 5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges. Cancer. 1997 Jun 15;79(12):2282–2308. doi: 10.1002/(sici)1097-0142(19970615)79:12<2282::aid-cncr2>3.0.co;2-o. [DOI] [PubMed] [Google Scholar]
  16. Regula J., MacRobert A. J., Gorchein A., Buonaccorsi G. A., Thorpe S. M., Spencer G. M., Hatfield A. R., Bown S. G. Photosensitisation and photodynamic therapy of oesophageal, duodenal, and colorectal tumours using 5 aminolaevulinic acid induced protoporphyrin IX--a pilot study. Gut. 1995 Jan;36(1):67–75. doi: 10.1136/gut.36.1.67. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Rud E., Gederaas O., Høgset A., Berg K. 5-aminolevulinic acid, but not 5-aminolevulinic acid esters, is transported into adenocarcinoma cells by system BETA transporters. Photochem Photobiol. 2000 May;71(5):640–647. doi: 10.1562/0031-8655(2000)071<0640:aabnaa>2.0.co;2. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES